Journals / Turkish Neurosurgery / 2014 / Cilt: 24 - Sayı: 5

A Case of Primary Dural Lymphoma: Diffuse Large B-Cell Type

Bir Primer Dural Lenfoma Olgusu: Difüz Büyük B-Hücre Tipi

Pages
799–803
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Until the optimal standard management protocol is established, the treatment should be with an individualized multidisciplinary approach and continued follow-up and clinical surveillance are recommended for every patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:lymphoma is a subentity of primary leptomeningeal lymphoma and arises from the dura mater without systemic disease.
📊
Key Findings & Data:A 47-year-old woman presented with an indolent mass in the right frontal region.
💡
Conclusion & Impact:Until the optimal standard management protocol is established, the treatment should be with an individualized multidisciplinary approach and continued follow-up and clinical surveillance are recommended for every patient.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

lymphoma is a subentity of primary leptomeningeal lymphoma and arises from the dura mater without systemic disease. A 47-year-old woman presented with an indolent mass in the right frontal region. The patient's physical examination demonstrated no focal neurological abnormality. Magnetic resonance imaging (MRI) study revealed a mass lesion in the right frontal region. The patient underwent a right frontal craniectomy and removal of tumor. Histological diagnosis was diffuse large B-cell lymphoma (DLBCL). The patient received chemotherapy with rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone (R-CHOP protocol) every 3 weeks for six cycles. The patient was discharged without neurological deficit and no evidence of tumor recurrence. There was no systemic dissemination of disease 72 months after the surgery. Until the optimal standard management protocol is established, the treatment should be with an individualized multidisciplinary approach and continued follow-up and clinical surveillance are recommended for every patient.

Özet

Primer leptomeningeal lenfoma, primer merkez sinir sistemi (MSS) lenfomasının bir alt tipi olan çok nadir bir hastalıktır. Primer dural lenfoma, primer leptomeningeal lenfomanın bir alt tipidir ve sistemik hastalık olmadan dura materden gelişir. 47 yaşında bir kadın, sağ frontal bölgede ağrısız bir kitleyle başvurdu. Hastanın fiziksel incelemesi herhangi bir fokal nörolojik anormallik göstermedi. Manyetik rezonans görüntüleme (MRG) incelemesi sağ frontal bölgede bir kitle gösterdi. Hastaya sağ frontal kraniyektomi ve tümör eksizyonu işlemi yapıldı. Histolojik tanı difüz büyük B-hücreli lenfomaydı (DLBCL). Hastaya rituksimab, siklofosfamid, adriamisin, vinkristin, ve prednizolon (R-CHOP protokolü) ile altı kür boyunca 3 haftada bir kemoterapi verildi. Hasta herhangi bir nörolojik defisit ve tümör nüksü bulgusu olmadan taburcu edildi. Cerrahiden 72 ay sonra hastalığın sistemik yayılması yoktu. Optimum standart takip protokolü belirleninceye kadar tedavi multidisipliner bir yaklaşımla hastaya özelleştirilmelidir ve her hasta için devamlı takip ve klinik gözetim önerilir.

🔖

Cite This Article

LEE, W. H., KIM, B., KIM, M. S. (2014). A Case of Primary Dural Lymphoma: Diffuse Large B-Cell Type. Turkish Neurosurgery, Cilt: 24 - Sayı: 5, 799–803. https://ajindex.com/articles/404837

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18: 3144-3150, 2000 2. Benouaich A, Delord JP, Danjou M, Richaud J, Urocoste E, Soum F, Aziza R: Primary dural lymphoma: A report of two cases with review of the literature. Rev Neurol (Paris) 159: 652-658, 2003 3. Freudenstein D, Bornemann A, Ernemann U, Boldt R, Duffner F: Intracranial malignant B-cell lymphoma of the dura. Clin Neuropathol 19: 34-37, 2000 4. Goetz P, Lafuente J, Revesz T, Galloway M, Dogan A, Kitchen N: Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma. J Neurosurg 96: 611-614, 2002 5. Iwamoto FM, Abrey LE: Primary dural lymphomas: A review. Neurosurg Focus 21 (5): E5, 2006 6. Iwamoto FM, DeAngelis LM, Abrey LE: Primary dural lymphomas: A clinicopathologic study of treatment and outcome in eight patients. Neurology 66: 1763-1765, 2006 7. Jellinger K, Radaskiewicz T, Slowik F: Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol Suppl 6: 95-102, 1975 8. Johnson MD, Kinney MC, Scheithauer BW, Briley RJ, Hamilton K, McPherson WF, Barton Jr. JH: Primary intracerebral hodgkin's disease mimicking meningioma: Case report. Neurosurgery 47: 454-457, 2000 9. Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL: Dural lesions mimicking meningiomas. Hum Pathol 33: 1211-1226, 2002 10. Kim HJ, Ha CK, Jeon BS: Primary leptomeningeal lymphoma with long-term survival: A case report. J Neurooncol 48: 47-49, 2000 11. Lachance D, O'Neill B, Macdonald D, Jaeckle K, Witzig T, Li CY, Posner JB: Primary leptomeningeal lymphoma report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology 41: 95-100, 1991 12. Maher EA, Fine HA: Primary CNS lymphoma. Semin Oncol 26: 346-356, 1999 13. Miranda RN, Glantz LK, Myint MA, Levy N, Jackson CL, Rhodes CH, Glantz MJ, Medeiros LJ: Stage IE non-hodgkin's lymphoma involving the dura: A clinicopathologic study of five cases. Arch Pathol Lab Med 120: 254-260, 1996 14. Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. J Neurosurg 65: 600-607, 1986 15. Said R, Rizk S, Dai Q: Clinical challenges of primary diffuse large B-cell lymphoma of the dura: Case report and literature review. ISRN Hematol 2011:945212, 2011 16. Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, Felman P, Coiffier B: Mucosa-associated lymphoid tissue gast